APOTEEK HANCOUR
ActiveAPOTEEK HANCOUR has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €102k and a net result of €76k. Equity is growing by ~3.6% per year across the filed fiscal years. Its solvency ranks better than 40% of 10331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability96=
Solvency54▲+23
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 1.51 against 1.08 in 2024; short-term debt: 57.4% and cash: 13.9% of total assets), but 71.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
28.8%
Return on assets
21.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-03-2026, 140 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
140 d early
2024
48 d early
2023
29 d early
2022
18 d late
2021
16 d early
2020
1 d early
2019
27 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€102k▲ 290%
2024 · €26k
2018: €100k
2019: €73k
2020: €21k
2021: €22k
2022: €22k
2023: €25k
2024: €26k
2018 → 2025
Total assets
€355k▼ 16.7%
2024 · €426k
2018: €306k
2019: €526k
2020: €507k
2021: €459k
2022: €456k
2023: €381k
2024: €426k
2018 → 2025
Net result
€76k▼ 16.7%
2024 · €91k
2018: €-12k
2019: €31k
2020: €29k
2021: €50k
2022: €87k
2023: €63k
2024: €91k
2018 → 2025
Working capital
€104k▲ 276%
2024 · €28k
2018: €129k
2019: €129k
2020: €24k
2021: €19k
2022: €18k
2023: €24k
2024: €28k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€22k-€22k▲ 2.1%€25k▲ 12.9%€26k▲ 5.3%€102k▲ 290%
Operating result€73k-€124k▲ 69.3%€91k▼ 26.4%€126k▲ 38.3%€116k▼ 7.7%
Net result€50k-€87k▲ 75.5%€63k▼ 28.1%€91k▲ 45.3%€76k▼ 16.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €355k
Fixed assets
€47k▼ 24.7%
Current assets
€307k▼ 15.3%
Equity and liabilities €355k
Equity
€102k▲ 290%
Debt
€252k▼ 36.8%
The debt ratio falls from 93.8% to 71.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€132k▼
2024 · €143k
Cash flow
€92k▼
2024 · €109k
Solvency
28.8%▲
2024 · 6.2%
Current ratio
1.51▲
2024 · 1.08
Quick ratio
1.22▲
2024 · 0.89
Debt / equity
2.47▼
2024 · 15.23
ROE
74.3%▼
2024 · 348.0%
ROA
21.4%=
2024 · 21.4%
Interest coverage
8.75▼
2024 · 30.53
Debt
€252k▼
2024 · €400k
Debt ≤ 1 year
€204k▼
2024 · €335k
Debt > 1 year
€49k▼
2024 · €64k
Income taxes
€26k▼
2024 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€426k€355k▼
Fixed assets21/28€63k€47k▼
Tangible fixed assets22/27€62k€46k▼
Plant, machinery and equipment23€2k€733▼
Furniture and vehicles24-€753
Other tangible fixed assets26€60k€45k▼
Financial fixed assets28€868€868=
Current assets29/58€363k€307k▼
Stocks and contracts in progress3€66k€59k▼
Stocks30/36€66k€59k▼
Amounts receivable within one year40/41€237k€197k▼
Trade receivables40€71k€81k▲
Other amounts receivable41€166k€115k▼
Current investments50/53€3€3▼
Cash at bank and in hand54/58€58k€49k▼
Deferred charges and accrued income490/1€3k€3k▲
Equity and liabilities
Total equity and liabilities10/49€426k€355k▼
Equity10/15€26k€102k▲
Contributions10/11€19k€19k=
Reserves13€2k€78k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€2k€78k▲
Profit (loss) carried forward14€5k€5k=
Amounts payable17/49€400k€252k▼
Amounts payable after more than one year17€64k€49k▼
Financial debts170/4€64k€49k▼
Amounts payable within one year42/48€335k€204k▼
Current portion of amounts payable after more than one year42€22k€15k▼
Financial debts43€13k€0▼
Credit institutions430/8€13k€0▼
Trade debts44€33k€47k▲
Suppliers440/4€33k€47k▲
Taxes, remuneration and social security45€33k€16k▼
Taxes450/3€33k€16k▼
Other amounts payable47/48€235k€126k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17k€16k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0-
Other operating charges640/8€772€1k▲
Gross operating margin9900€144k€133k▼
Operating profit (loss)9901€126k€116k▼
Financial income75/76B€3k€1k▼
Recurring financial income75€3k€1k▼
Financial charges65/66B€5k€15k▲
Recurring financial charges65€5k€15k▲
Profit (loss) for the period before taxes9903€124k€102k▼
Income taxes67/77€33k€26k▼
Profit (loss) for the period9904€91k€76k▼
Profit (loss) for the period to be appropriated9905€91k€76k▼
Appropriation of the result
Profit (loss) to be appropriated9906€95k€82k▼
Profit (loss) brought forward from the previous period14P€4k€5k▲
Transfer to equity691/2-€76k
To other reserves6921-€76k
Profit to be distributed694/7€90k€0▼
Return on contributions (dividend)694€90k€0▼
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-03
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Equity above €100kEq €102k ▲290%
7 profitable years in a row build equity to €102k.
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €91k ▲45.3%
Operating result €126k, net result €91k, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
18-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 18 days late
2022
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 27 days late
2019
31-12
Financial
Back to profitnet €31k
Net result €31k after one loss-making year.
13-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 10 days late
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mortsel · 1 establishment unit since 1961
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Antwerpsestraat 3002640 MortselGround area
313 m²
Building footprint
156 m²
Volume, LiDAR
1,017 m³
Parcel 11029A0047/00N008, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Antwerpsestraat 300, 2640 Mortsel
since 19612.004.934.471
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11029A0047/00N008 | Flanders | 313 m² | 1 · 156 m² | 9.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Pharma Meerhout
BE 0479.458.231
Meerhout · Eq €102k
PHARMACIE LEPIECE
BE 0870.964.087
Chaudfontaine · Eq €102k
APOTHEEK MEES ZOLDER
BE 0454.292.273
Heusden-Zolder · Eq €102k
APOTEEK BRICHAU
BE 0439.520.559
Halle · Eq €102k
PharmaConseil
BE 0826.485.134
Verviers · Eq €102k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,424 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-01-1968
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.